EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Supercomputer-Based Virtual Screening for Deoxyribonucleic Acid Methyltransferase 1 Inhibitors as Novel Anticancer Agents

Lara Johanna Friedrich iD, Axel Guthart, Min Zhou iD, Paola B Arimondo iD, Thomas Efferth iD, Mona Dawood

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252211870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Lara Johanna Friedrich und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mai…. Hauptthemen laut MEDLINE: Antineoplastic Agents, DNA (Cytosine-5-)-Methyltransferase 1, Molecular Docking Simulation, Enzyme Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting epigenetics is a new strategy to treat cancer and develop novel epigenetic drugs with anti-tumor activity. DNA methyltransferases transfer the methyl group from S-adenosyl-L-methionine (SAM) to the cytosine residue in a CpG island, leading to the transcription silencing of the gene. Hypermethylation can frequently be observed in several tumor types. Hence, the inhibition of DNMT1 has become a novel approach to cure cancer. In this study, virtual screening and molecular docking were performed for more than 11,000 ligands from the ZINC15 database to discover new hypomethylation agents. Four candidate compounds were further tested for their effects on DNMT1 in silico and in vitro. Compounds 2 and 4 showed the best DNMT1 inhibitory activity, but only compound 4 was able to inhibit the growth of several cancer cell lines. The hypomethylation of the luciferase gene by compound 4 was verified by a CMV- luciferase assay using KG-1 cells. Additionally, compound 4 suppressed cell migration in a dose- and time-dependent manner in the wound healing assay. Moreover, cell cycle analyses demonstrated that compound 4 arrested CCRF-CEM cells and MDA-MB-468 cells in the G0/G1 phase. Also, compound 4 significantly induced early and late apoptosis in a dose-dependent manner. In conclusion, we introduce compound 4 as a novel DNMT1 inhibitor with anticancer activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsDNA (Cytosine-5-)-Methyltransferase 1Molecular Docking SimulationEnzyme InhibitorsHumansCell Line, TumorDNA MethylationCell ProliferationCell MovementApoptosis

Stichwörter der Autor:innen

DNA methylationcancerepigeneticsmolecular docking and simulationvirtual drug screening

Substanzen

Antineoplastic AgentsDNA (Cytosine-5-)-Methyltransferase 1Enzyme InhibitorsDNMT1 protein, human

Autor:innen und Institutionen

  • Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany.
  • Epigenetic Chemical Biology, Institute Pasteur, Université Paris Cité, CNRS UMR3523, 28 Rue du Docteur Roux, 75724 Paris, France.

ORCID-Profile: Lara Johanna Friedrich, Min Zhou, Paola B Arimondo, Thomas Efferth

Zitieren

APA

Friedrich, L. J., Guthart, A., Zhou, M., Arimondo, P. B., Efferth, T., & Dawood, M. (2024). Supercomputer-Based Virtual Screening for Deoxyribonucleic Acid Methyltransferase 1 Inhibitors as Novel Anticancer Agents. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252211870

Vancouver

Friedrich LJ, Guthart A, Zhou M, Arimondo PB, Efferth T, Dawood M. Supercomputer-Based Virtual Screening for Deoxyribonucleic Acid Methyltransferase 1 Inhibitors as Novel Anticancer Agents. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252211870

BibTeX
@article{Friedrich2024,
  author = {Friedrich, Lara Johanna and Guthart, Axel and Zhou, Min and Arimondo, Paola B and Efferth, Thomas and Dawood, Mona},
  title = {Supercomputer-Based Virtual Screening for Deoxyribonucleic Acid Methyltransferase 1 Inhibitors as Novel Anticancer Agents},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252211870}
}
Kostenlos starten →